Neuronetics, Inc..
STIM.US | Manufacture of medical and dental instruments and supplies
Neuronetics, Inc. is a commercial-stage medical device company focused on developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. The company's primary product is NeuroStar Advanced Therapy System, a non-invasive and non-systemic neuromo...Show More
Better Health for All
-10
The company's core product, NeuroStar TMS Therapy, is FDA-cleared for major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and anxious depression.
1
It has delivered over 6.9 million treatments, with fewer than 5% of people discontinuing treatment due to adverse events in clinical trials.
2
Clinical data shows high efficacy, with 83% response and 62% remission rates (clinician-rated) for MDD, and 78% response and 48% remission for adolescents.
3
The company's entire business is devoted to improving health outcomes for these conditions. The product has no established negative health outcomes.
4
However, the safety record indicates a rare risk of seizure (<0.1% of people), and one patient reported severe adverse effects including suicidal ideation after treatment.
5
The cost of TMS treatment is $300 per session, with annual costs of $11,886, significantly higher than the $1,123 cost of pharmaceutical regimens.
6
While Lucet Health's policy update in February 2024 reduced antidepressant medication attempts required for TMS eligibility from four to two, impacting approximately 9 million covered lives, the treatment remains expensive.
7
The company provides information on side effects and contraindications, but one patient reported that risks were not fully disclosed, indicating some gaps in transparency.
8
The company's focus is directly on mental health treatment.
Fair Money & Economic Opportunity
0
No evidence available to assess Neuronetics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
Neuronetics' Indeed Work Wellbeing Score is 60/100, indicating growing trust among employees.
1
The company offers a 401k plan and provides health insurance, dental, vision, FSA, HSA, life insurance, and disability benefits.
2
There is no public record of labor law or human rights violations.
3
Fair Trade & Ethical Sourcing
0
No specific, quantitative evidence was found in the provided articles for any of the KPIs related to Fair Trade & Ethical Sourcing. While the company has policies and due diligence processes in place, particularly concerning conflict minerals,
1
the articles do not provide data such as the percentage of spend covered by fair-trade certifications, average audit frequency, number of substantiated forced or child labor incidents, percentage of suppliers with traceable provenance data, median remediation speed, percentage of contracts with ethical-sourcing clauses, share of spend on high-risk materials, or procurement budget directed to diverse suppliers.
2
Honest & Fair Business
-60
The company has a Code of Business Conduct and Ethics (dated August 2025) which includes a policy for whistleblowers.
1
This policy explicitly states that confidentiality agreements will not prevent employees from reporting waste, fraud, and abuse to the company or governmental entities.
2
It provides multiple reporting channels, including a Compliance Officer, a dedicated email/website, and an anonymous toll-free hotline (877-472-2110), and emphasizes non-retaliation for good faith reporting.
3
Neuronetics has an anti-corruption policy that strictly prohibits bribery and complies with all anti-corruption laws, including the FCPA and U.K. Bribery Act, as well as international trade laws, anti-money laundering laws, and insider trading laws.
4
The company is a member of the Medical Device Manufacturers Association (MDMA) and complies with the MDMA Revised Code of Conduct on Interactions with Healthcare Providers.
5
However, there is no specific evidence of the extent of independent verification of ethical claims beyond this membership and compliance.
Kind to Animals
0
No evidence available to assess Neuronetics, Inc. on Kind to Animals.
No War, No Weapons
0
No evidence was found in the provided article to assess Neuronetics, Inc. against any of the 'No War, No Weapons' KPIs.
1
The article summary explicitly states that no data on the requested metrics is present.
2
Planet-Friendly Business
0
Neuronetics reported a total carbon footprint of 1,850 metric tons CO2 in 2023, which is equivalent to 0.00185 M tCO₂e.
1
This represents a 4.2% reduction from the previous year.
2
The company sourced 18.3% of its total energy consumption from renewables in 2023, utilizing 448,350 kWh out of 2,450,000 kWh.
3
For waste management, Neuronetics achieved an 82.5% recycling rate for electronic waste in 2023, from 6.2 metric tons generated.
4
The company also reported that its 2nd Generation INGREZZA manufacturing process reduces total waste by 53%, water use by 32%, and cycle-time by 43%.
5
No environmental compliance violations were reported in 2023.
6
Respect for Cultures & Communities
0
No specific, concrete evidence was found in the provided articles regarding Neuronetics, Inc.'s (STIM.US) performance on any of the KPIs related to 'Respect for Cultures & Communities'. The articles primarily focus on financial results, career opportunities, human resources, and internal diversity and inclusion philosophy, without providing data on external community engagement, cultural impact, or related metrics.
Safe & Smart Tech
0
The company allows users to access, update, or request deletion of their personal data.
1
Neuronetics' NeuroStar Advanced Therapy System received clearance from the FDA in 2008 and regulatory approval in Japan in September 2017.
2
The company states its commitment to complying with applicable laws in all countries where it operates, including anti-corruption, international trade, anti-money laundering, labor, and environmental regulations.
3
Neuronetics has implemented multi-factor authentication.
4
The company regularly assesses risks from cybersecurity threats, monitors information systems for potential vulnerabilities, and tests systems pursuant to cybersecurity policies.
5
Neuronetics will keep personal data only as long as reasonably required for business purposes and in accordance with legal or ethical retention requirements.
6
The company collaborates with third parties to assess the effectiveness of cybersecurity prevention and response systems through penetration testing and best practice reviews.
7
Zero Waste & Sustainable Products
0
Neuronetics' financial reports for 2024 and a business update document state that no regulatory actions, violations, fines, or compliance issues are mentioned.
1
This indicates a standard compliance approach with no reported waste disposal violations.
2